Assessments of the transcriptome from leukocytes and whole blood in COVID-19 may not be interchangeable and will need cross-validating, although both datasets demonstrated no association between IL-1β or IL-6 activity and severity of disease. This evidence concerns the gene IL6 and COVID-19.